These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31107370)

  • 1. Superimposed Clostridium difficile Infection During Checkpoint Inhibitor Immunotherapy-induced Colitis.
    Babacan NA; Tanvetyanon T
    J Immunother; 2019; 42(9):350-353. PubMed ID: 31107370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors : Antibiotics immune checkpoint inhibitors in advanced NSCLC.
    Schett A; Rothschild SI; Curioni-Fontecedro A; Krähenbühl S; Früh M; Schmid S; Driessen C; Joerger M
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):121-131. PubMed ID: 31745593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
    Brinda BJ; Pasikhova Y; Quilitz RE; Thai CM; Greene JN
    J Hosp Infect; 2017 Apr; 95(4):426-432. PubMed ID: 28153556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of Clostridium difficile in pseudomembranous and antibiotic-associated colitis.
    Panichi G
    Chemioterapia; 1987 Jun; 6(2 Suppl):493-4. PubMed ID: 2978388
    [No Abstract]   [Full Text] [Related]  

  • 5. Fecal Microbiota Transplantation in Recurrent NAP1/B1/027 Clostridium Difficile Infection (CDI) Resistant to Vancomycin and Metronidazole in a Patient with Ulcerative Colitis (UC): A Case Report.
    Preda CM; Meianu C; Sandra I; Becheanu G; Dumbrava M; Manuc M; Diculescu M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):563-7. PubMed ID: 30044904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis.
    Abu-Sbeih H; Herrera LN; Tang T; Altan M; Chaftari AP; Okhuysen PC; Jenq RR; Wang Y
    J Immunother Cancer; 2019 Sep; 7(1):242. PubMed ID: 31488205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile colitis associated with cancer chemotherapy.
    Cudmore MA; Silva J; Fekety R; Liepman MK; Kim KH
    Arch Intern Med; 1982 Feb; 142(2):333-5. PubMed ID: 7036924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile infection and immune checkpoint inhibitor-induced colitis in melanoma: 18 cases and a review of the literature.
    Vuillamy C; Arnault JP; Fumery M; Mortier L; Monestier S; Mansard S; Bens G; Duval-Modeste AB; Funck-Brentano E; Jeudy G; Machet L; Chaby G; Dadban A; Lok C;
    Melanoma Res; 2023 Jun; 33(3):192-198. PubMed ID: 36995276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile colitis associated with the use of antineoplastic agents.
    Miller SD; Koornhof HJ
    Eur J Clin Microbiol; 1984 Feb; 3(1):10-3. PubMed ID: 6705768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case-Control Study.
    Eshet Y; Baruch EN; Shapira-Frommer R; Steinberg-Silman Y; Kuznetsov T; Ben-Betzalel G; Daher S; Gluck I; Asher N; Apter S; Schachter J; Bar J; Boursi B; Markel G
    Cancer Immunol Res; 2018 Dec; 6(12):1453-1458. PubMed ID: 30275274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Clinical Impact of Anti-TNFα Treatment of Severe Immune Checkpoint Inhibitor-induced Colitis in Advanced Melanoma: The Mecolit Survey.
    Lesage C; Longvert C; Prey S; Maanaoui S; Dréno B; Machet L; Zehou O; Kramkimel N; Jeudy G; Skowron F; Aubin F; Visseaux L; Mansard S; Dereure O; Lesage FX; Guillot B;
    J Immunother; 2019 Jun; 42(5):175-179. PubMed ID: 31090656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic bowel infection after corticosteroid dosage tapering in a stage IV lung cancer patient with tislelizumab-related colitis.
    Ni J; Zhang X; Zhang L
    Thorac Cancer; 2020 Jun; 11(6):1699-1702. PubMed ID: 32239681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy.
    Suresh K; Psoter KJ; Voong KR; Shankar B; Forde PM; Ettinger DS; Marrone KA; Kelly RJ; Hann CL; Levy B; Feliciano JL; Brahmer JR; Feller-Kopman D; Lerner AD; Lee H; Yarmus L; Hales RK; D'Alessio F; Danoff SK; Naidoo J
    J Thorac Oncol; 2019 Mar; 14(3):494-502. PubMed ID: 30503891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
    Garcia PG; Chebli LA; da Rocha Ribeiro TC; Gaburri PD; de Lima Pace FH; Barbosa KVBD; Costa LA; de Almeida Cruz W; de Assis IC; Moraes BRM; Zanini A; Chebli JMF
    Int J Colorectal Dis; 2018 Sep; 33(9):1285-1294. PubMed ID: 29926235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.
    Scardina TL; Kang Martinez E; Balasubramanian N; Fox-Geiman M; Smith SE; Parada JP
    Pharmacotherapy; 2017 Apr; 37(4):420-428. PubMed ID: 28226419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.
    Suresh K; Voong KR; Shankar B; Forde PM; Ettinger DS; Marrone KA; Kelly RJ; Hann CL; Levy B; Feliciano JL; Brahmer JR; Feller-Kopman D; Lerner AD; Lee H; Yarmus L; D'Alessio F; Hales RK; Lin CT; Psoter KJ; Danoff SK; Naidoo J
    J Thorac Oncol; 2018 Dec; 13(12):1930-1939. PubMed ID: 30267842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pembrolizumab induced steroid resistant immune mediated colitis and concurrent Clostridioides difficile infection.
    Preda CM; Marin RI; Becheanu G; Neacsu F; Manuc T; Manuc M
    J Gastrointestin Liver Dis; 2021 Sep; 30(3):411-413. PubMed ID: 34551037
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy.
    Fujita K; Kim YH; Kanai O; Yoshida H; Mio T; Hirai T
    Respir Med; 2019 Jan; 146():66-70. PubMed ID: 30665520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for relapsing and severe colitis caused by Clostridium difficile infection].
    Vojtilová L; Pýchová M; Freibergerová M; Juránková J; Bortlíček Z; Husa P
    Vnitr Lek; 2013 Jan; 59(1):23-30. PubMed ID: 23427999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.